Search Results

Below are the search engine results of your query.

Showing 11-14 of 14 results for "R142b"

The Chemours Company Reports Third Quarter 2022 Results

Continued strength in APM and TSS despite uncertain macroeconomic conditions The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced its financial results for the third quarter 2022.

The Chemours Company Reports Third Quarter 2016 Results; Significant Earnings and Margins Increases Driven by Progress on Transformation Plan and Improved Market Conditions

Third Quarter 2016 Highlights Net Sales of $1.4 billion Net Income of $204 million , or $1.11 per diluted share, including gain on asset sales of $169 million , impairment charges of $46 million , interest expense of $51 million and restructuring costs of $14 million Adjusted EBITDA of $268 million Adjusted Net Income of $112 million , or $0.61 per diluted share Other Highlights Continued progress...

Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

Eleventh paragraph, first and second sentences of release dated February 28, 2024 should read: At December 31, 2023, the Company maintained cash and cash equivalents of $1.2 billion; it has restricted cash and restricted cash equivalents of $604 million primarily relating to the U.S.

The Chemours Company Reports Strong Third Quarter Results and Increases Full-Year 2021 Outlook

Market strength and operational excellence drove strong quarterly performance, raising outlook as confidence builds The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions today announces its financial results for the third quarter 202...